Germany
Germany · page 3
- Industry Trends
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
- Industry Trends
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire Berlin’s Sanity Group for up to 227 million euros, financed in large part by a roughly 65 million Canadian dollar capital injection from its largest shareholder, British American Tobacco (BAT).
- Industry Trends
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
- International Regulation
Germany’s Cannabis Future: Political Posturing vs. Market Reality
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical cannabis prescriptions, and potentially transforming the industry.
- UK & Europe
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
- International Regulation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
- Industry Trends
Why is No One Talking About Germany’s Oversupply Problem?
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
- UK & Europe
Legal Sources Now the First Choice for Cannabis Users in Germany
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
- UK & Europe
Cannabis Researchers Call for Implementation of Second Pillar of the KCanG
When Germany introduced the Recreational Cannabis Act (KCanG), it not only legalised home cultivation and consumption for adults but also laid the groundwork for scientifically monitored pilot projects allowing the legal sale of cannabis at authorised distribution points.
- UK & Europe
Germany Advances MedCanG Amendments to Restrict Prescriptions and Telemedicine Use
Just a week after the first official data on the impact of Germany’s cannabis reforms was published, the Federal Cabinet approved proposals to restrict medical cannabis prescriptions across the country.
- UK & Europe
‘No One Expected the Surge’: Grunhorn on How Telemedicine Took German Medical Cannabis by Storm
Since April 2024, Germany has been firmly cemented at the centre of the global cannabis conversation, and for good reason.
- Investment & Finance
UK Clinic Releaf Expands into Germany, Aiming for Top Spot Within Six Months
UK clinic Releaf expands into Germany, leveraging its digital health ecosystem to capture market share in Europe’s fast-growing medical cannabis sector.
